Jeffrey L. Ives is Director at Cara Therapeutics, Inc. (CARA). They have made 7 open-market trades across 1 company since 2019, most recently 2026-06-03.
CIK 0001614096
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABOS | SELL · 10b5-1 | 2023-08-17 | 2023-08-18 | $6.49 | $526K | +1.1% | -18.6% | -64.4% |
| CARA | SELL · 10b5-1 | 2022-07-15 | 2022-07-19 | $9.05 | $33K | -8.7% | +16.2% | +10.9% |
| CARA | SELL | 2021-11-12 | 2021-11-16 | $16.04 | $262K | -17.2% | -19.9% | -32.3% |
| CARA | SELL · 10b5-1 | 2021-06-07 | 2021-06-07 | $13.05 | $33K | +8.8% | +2.8% | +16.0% |
| CARA | SELL | 2020-11-19 | 2020-11-24 | $15.75 | $39K | -0.8% | +3.8% | +33.1% |
| CARA | SELL · 10b5-1 | 2020-06-01 | 2020-06-03 | $16.00 | $16K | -2.7% | +10.2% | -5.5% |
| CARA | SELL · 10b5-1 | 2020-05-12 | 2020-05-14 | $16.00 | $40K | +7.1% | +3.5% | +13.4% |
| CARA | SELL · 10b5-1 | 2020-04-21 | 2020-04-21 | $16.00 | $40K | -12.1% | -1.7% | +10.2% |
| CARA | SELL · 10b5-1 | 2020-03-04 | 2020-03-06 | $16.00 | $40K | -35.1% | -4.6% | +11.2% |
| CARA | SELL · 10b5-1 | 2020-02-03 | 2020-02-05 | $16.23 | $41K | +0.8% | -10.4% | -14.2% |
| CARA | SELL · 10b5-1 | 2020-01-02 | 2020-01-06 | $16.13 | $40K | +10.8% | +11.4% | -12.1% |
| CARA | SELL | 2019-12-02 | 2019-12-04 | $25.83 | $129K | +1.2% | -10.5% | -11.8% |
| CARA | SELL | 2019-11-01 | 2019-11-05 | $20.68 | $52K | +4.7% | -20.2% | -19.3% |
| CARA | SELL · 10b5-1 | 2019-10-01 | 2019-10-03 | $18.21 | $46K | +1.7% | +7.0% | -19.0% |
| CARA | SELL | 2019-09-03 | 2019-09-05 | $23.31 | $58K | +1.1% | -18.9% | -27.4% |
| CARA | SELL | 2019-08-01 | 2019-08-05 | $23.24 | $116K | +0.7% | +2.2% | -9.3% |
| CARA | SELL | 2019-07-01 | 2019-07-03 | $21.75 | $54K | +18.3% | +2.7% | -18.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.